表紙
市場調查報告書

Cyclooxygenase2抑制劑的全球市場:各適應症、類型、給藥途徑、終端用戶、流通管道及各地區的預測 (2020-2026年)

Global Cyclooxygenase2 inhibitor Market Size study, by Indication, Types, Route of Administration, End-Users, Distribution Channel and Regional Forecasts 2020-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 939901
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Cyclooxygenase2抑制劑的全球市場:各適應症、類型、給藥途徑、終端用戶、流通管道及各地區的預測 (2020-2026年) Global Cyclooxygenase2 inhibitor Market Size study, by Indication, Types, Route of Administration, End-Users, Distribution Channel and Regional Forecasts 2020-2026
出版日期: 2020年05月01日內容資訊: 英文
簡介

稱為COX-2抑制劑的Cyclooxygenase2抑制劑,是緩和疼痛和發炎所使用的非類固醇消炎劑。Cyclooxygenase-2抑制劑,也作為結腸息肉的預防及抗癌藥研究。對症狀的認識高漲,止痛藥等的COX-2抑制劑的高採用率高,推動全球Cyclooxygenase2抑制劑市場發展。再加上類風濕性關節炎等的慢性疾病的盛行率上升,也可能推動這個需求增加。

本報告提供全球Cyclooxygenase-2抑制劑市場相關調查,市場概要,各類型、給藥途徑、終端用戶,及各地區的市場分析與預測,競爭情形分析,並提供主要企業簡介等資訊。

第1章 摘要整理

第2章 全球Cyclooxygenase-2抑制劑市場定義和範圍

第3章 全球Cyclooxygenase-2抑制劑市場動態

  • 影響分析

第4章 產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的建議與結論

第5章 全球Cyclooxygenase-2抑制劑市場:各適應症

  • 市場概述
  • 潛在性分析
  • 市場估計、預測: 各適應症
  • 子區隔分析
    • 骨關節炎
    • 類風濕性關節炎
    • 其他

第6章 全球Cyclooxygenase-2抑制劑市場:各類型

  • 市場概述
  • 潛在性分析
  • 市場估計、預測:各類型
  • 子區隔分析
    • 選擇的COX-2抑制劑
    • 非選擇的COX-2抑制劑

第7章 全球Cyclooxygenase-2抑制劑市場:各給藥途徑

  • 市場概述
  • 潛在性分析
  • 市場估計、預測: 各給藥途徑
  • 子區隔分析
    • 口服
    • 非口服
    • 其他

第8章 全球Cyclooxygenase-2抑制劑市場:各終端用戶

  • 市場概述
  • 潛在性分析
  • 市場估計、預測: 各終端用戶
  • 子區隔分析
    • 醫院
    • 專門診所
    • 其他

第9章 全球Cyclooxygenase-2抑制劑市場:地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 其他歐洲
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地區

第10章 競爭資訊

  • 主要市場策略
  • 企業簡介
    • Pfizer Inc.
    • Bayer AG
    • Novartis AG
    • Sabinsa
    • Cadila Pharmaceuticals
    • Mylan N.V.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • Aurobindo Pharma
    • Cipla Inc.
    • Torrent Pharmaceuticals Ltd.

第11章 調查流程

目錄

Global Cyclooxygenase2 inhibitor Market is valued approximately USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. Cyclooxygenase2 inhibitor also known as COX-2 inhibitor, is a nonsteroidal anti-inflammatory drug used to relieve pain and inflammation. Cyclooxygenase-2 inhibitors are being studied in the prevention of colon polyps, and as anticancer drugs. Factors such as rising awareness of the condition, high acceptance rate of cox 2 inhibitors, such as painkillers, are responsible for the development of the global market for cyclooxygenase 2 inhibitors. In addition, the growing prevalence of chronic diseases such as rheumatoid arthritis may also fuel this demand development. For instance, rheumatoid arthritis is a chronic disease affecting over 1.3 million Americans and as much as 1% of the worldwide population in 2018. However, safety issues and severe side effects of cox 2 inhibitors can restrain the growth of this market.

The regional analysis of Coronavirus Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Due to increasing awareness of chronic disease diagnosis and high prevalence, Asia-Pacific is projected to account for the largest market share for cyclooxygenase 2 inhibitor market in the coming years. Europe is considered to hold promising opportunities for development in the coming years, while North America is considered to lead the rise due to global players' focus on emerging technologies.

Major market player included in this report are:

Pfizer Inc.

Bayer AG

Novartis AG

Sabinsa

Cadila Pharmaceuticals

Mylan N.V.

Teva Pharmaceutical Industries Ltd.

Alembic Pharmaceuticals Limited

Aurobindo Pharma

Cipla Inc.

Torrent Pharmaceuticals Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Indication:

Osteoarthritis

Rheumatoid arthritis

Others

By Type:

Selective cox 2 inhibitor

Non-selective cox 2 inhibitor

By Route of Administration:

Oral

Parenteral

Others

By End-Users:

Hospitals

Specialty Clinics

Others

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017, 2018

Base year - 20198

Forecast period - 2020 to 2026

Target Audience of the Global Cyclooxygenase2 inhibitor Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
    • 1.2.1. Global Cyclooxygenase2 inhibitor Market, by Region, 2018-2026 (USD Billion)
    • 1.2.2. Global Cyclooxygenase2 inhibitor Market, by Indication, 2018-2026 (USD Billion)
    • 1.2.3. Global Cyclooxygenase2 inhibitor Market, by Route of Administration, 2018-2026 (USD Billion)
    • 1.2.4. Global Cyclooxygenase2 inhibitor Market, by End-Users, 2018-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cyclooxygenase2 inhibitor Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cyclooxygenase2 inhibitor Market Dynamics

  • 3.1. Global Cyclooxygenase2 inhibitor Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Cyclooxygenase2 inhibitor Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cyclooxygenase2 inhibitor Market, by Indication

  • 5.1. Market Snapshot
  • 5.2. Global Cyclooxygenase2 inhibitor Market by Indication, Performance - Potential Analysis
  • 5.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by Indication 2016-2026 (USD Billion)
  • 5.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
    • 5.4.1. Osteoarthritis
    • 5.4.2. Rheumatoid arthritis
    • 5.4.3. Others

Chapter 6. Global Cyclooxygenase2 inhibitor Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Cyclooxygenase2 inhibitor Market by Type, Performance - Potential Analysis
  • 6.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
  • 6.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
    • 6.4.1. Selective cox 2 inhibitor
    • 6.4.2. Non-selective cox 2 inhibitor

Chapter 7. Global Cyclooxygenase2 inhibitor Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Cyclooxygenase2 inhibitor Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by Route of Administration 2016-2026 (USD Billion)
  • 7.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Parenteral
    • 7.4.3. Others

Chapter 8. Global Cyclooxygenase2 inhibitor Market, by End-Users

  • 8.1. Market Snapshot
  • 8.2. Global Cyclooxygenase2 inhibitor Market by End-Users, Performance - Potential Analysis
  • 8.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by End-Users 2016-2026 (USD Billion)
  • 8.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Specialty Clinics
    • 8.4.3. Others

Chapter 9. Global Cyclooxygenase2 inhibitor Market, Regional Analysis

  • 9.1. Global Cyclooxygenase2 inhibitor Market, Regional Market Snapshot
  • 9.2. North America Global Cyclooxygenase2 inhibitor Market
    • 9.2.1. U.S. Global Cyclooxygenase2 inhibitor Market
      • 9.2.1.1. Indication breakdown estimates & forecasts, 2016-2026
      • 9.2.1.2. Type breakdown estimates & forecasts, 2016-2026
      • 9.2.1.3. Route of Administration breakdown estimates & forecasts, 2016-2026
      • 9.2.1.4. End-Users Channel breakdown estimates & forecasts, 2016-2026
    • 9.2.2. Canada Global Cyclooxygenase2 inhibitor Market
  • 9.3. Europe Global Cyclooxygenase2 inhibitor Market Snapshot
    • 9.3.1. U.K. Global Cyclooxygenase2 inhibitor Market
    • 9.3.2. Germany Global Cyclooxygenase2 inhibitor Market
    • 9.3.3. Rest of Europe Global Cyclooxygenase2 inhibitor Market
  • 9.4. Asia-Pacific Global Cyclooxygenase2 inhibitor Market Snapshot
    • 9.4.1. China Global Cyclooxygenase2 inhibitor Market
    • 9.4.2. India Global Cyclooxygenase2 inhibitor Market
    • 9.4.3. Japan Global Cyclooxygenase2 inhibitor Market
    • 9.4.4. Rest of Asia Pacific Global Cyclooxygenase2 inhibitor Market
  • 9.5. Latin America Global Cyclooxygenase2 inhibitor Market Snapshot
    • 9.5.1. Brazil Global Cyclooxygenase2 inhibitor Market
    • 9.5.2. Mexico Global Cyclooxygenase2 inhibitor Market
  • 9.6. Rest of The World Global Cyclooxygenase2 inhibitor Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Indication Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Bayer AG
    • 10.2.3. Novartis AG
    • 10.2.4. Sabinsa
    • 10.2.5. Cadila Pharmaceuticals
    • 10.2.6. Mylan N.V.
    • 10.2.7. Teva Pharmaceutical Industries Ltd.
    • 10.2.8. Alembic Pharmaceuticals Limited
    • 10.2.9. Aurobindo Pharma
    • 10.2.10. Cipla Inc.
    • 10.2.11. Torrent Pharmaceuticals Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. List Of Secondary Sources, Used In The Study Of Global Cyclooxygenase2 inhibitor Market
  • TABLE 2. List Of Primary Sources, Used In The Study Of Global Cyclooxygenase2 inhibitor Market
  • TABLE 3. Global Cyclooxygenase2 inhibitor Market, Report Scope
  • TABLE 4. Years Considered For The Study
  • TABLE 5. Exchange Rates Considered
  • TABLE 6. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Region 2016-2026 (USD Billion)
  • TABLE 7. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Indication 2016-2026 (USD Billion)
  • TABLE 8. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Type 2016-2026 (USD Billion)
  • TABLE 9. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Route of Administration 2016-2026 (USD Billion)
  • TABLE 10. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By End-Users 2016-2026 (USD Billion)
  • TABLE 11. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 12. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 13. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 14. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 15. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 16. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 17. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 18. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 19. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 20. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 21. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 22. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 23. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 24. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 25. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 26. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 27. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 28. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 29. U.S. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 30. U.S. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 31. U.S. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 32. Canada Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 33. Canada Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 34. Canada Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 35. Uk Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 36. Uk Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 37. Uk Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 38. Germany Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 39. Germany Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 40. Germany Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 41. Roe Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 42. Roe Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 43. Roe Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 44. China Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 45. China Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 46. China Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 47. India Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 48. India Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 49. India Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 50. Japan Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 51. Japan Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 52. Japan Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 53. Roapac Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 54. Roapac Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 55. Roapac Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 56. Brazil Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 57. Brazil Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 58. Brazil Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 59. Mexico Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 60. Mexico Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 61. Mexico Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 62. Rola Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 63. Rola Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 64. Rola Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 65. Row Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
  • TABLE 66. Row Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
  • TABLE 67. Row Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)

LIST OF FIGURES

  • FIG 1. Global Cyclooxygenase2 inhibitor Market, Research Methodology
  • FIG 2. Global Cyclooxygenase2 inhibitor Market, Market Estimation Techniques
  • FIG 3. Global Market Size Estimates & Forecast Methods
  • FIG 4. Global Cyclooxygenase2 inhibitor Market, Key Trends 2019
  • FIG 5. Global Cyclooxygenase2 inhibitor Market, Growth Prospects 2020-2026
  • FIG 6. Global Cyclooxygenase2 inhibitor Market, Porters 5 Force Model
  • FIG 7. Global Cyclooxygenase2 inhibitor Market, Pest Analysis
  • FIG 8. Global Cyclooxygenase2 inhibitor Market, Value Chain Analysis
  • FIG 9. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
  • FIG 10. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
  • FIG 11. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
  • FIG 12. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
  • FIG 13. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
  • FIG 14. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
  • FIG 15. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
  • FIG 16. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
  • FIG 17. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
  • FIG 18. Global Cyclooxygenase2 inhibitor Market, Regional Snapshot 2016 & 2026
  • FIG 19. North America Global Cyclooxygenase2 inhibitor Market 2016 & 2026 (USD Billion)
  • FIG 20. Europe Global Cyclooxygenase2 inhibitor Market 2016 & 2026 (USD Billion)
  • FIG 21. Asia Pacific Global Cyclooxygenase2 inhibitor Market 2016 & 2026 (USD Billion)
  • FIG 22. Latin America Global Cyclooxygenase2 inhibitor Market 2016 & 2026 (USD Billion)
  • FIG 23. Global Cyclooxygenase2 inhibitor Market, Company Market Share Analysis (2019)